2.1. Subjects
MAY
From May 2018 to December 2022, 40 SLE patients were enrolled in an allogeneic MSCT trial carried out at the Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University. All enrolled patients fulfilled at least four of 11 American College of Rheumatology criteria for the classification of SLE. Plasma samples (